Compared to controls, postmenopausal breast cancer women had significant and different estrogen-independent associations with the IgA+ and IgA− gut microbiota, suggesting that the gut microbiota may influence BC risk by altered metabolism, estrogen recycling, and immune pathways. Here, CD79A is linked to breast cancer.